Virtus ETF Advisers’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-241
| Closed | -$42.5K | – | 487 |
|
|
2023
Q1 | $42.5K | Sell |
241
-92
| -28% | -$16.2K | 0.02% | 434 |
|
|
2022
Q4 | $129K | Sell |
333
-39
| -10% | -$15.1K | 0.07% | 394 |
|
|
2022
Q3 | $125K | Buy |
372
+3
| +0.8% | +$1.01K | 0.05% | 387 |
|
|
2022
Q2 | $121K | Buy |
369
+10
| +3% | +$3.28K | 0.04% | 382 |
|
|
2022
Q1 | $157K | Sell |
359
-22
| -6% | -$9.62K | 0.07% | 220 |
|
|
2021
Q4 | $167K | Sell |
381
-30
| -7% | -$13.2K | 0.06% | 303 |
|
|
2021
Q3 | $229K | Sell |
411
-22
| -5% | -$12.3K | 0.1% | 233 |
|
|
2021
Q2 | $222K | Sell |
433
-127
| -23% | -$65.1K | 0.09% | 269 |
|
|
2021
Q1 | $437K | Buy |
560
+10
| +2% | +$7.8K | 0.18% | 166 |
|
|
2020
Q4 | $300K | Sell |
550
-19
| -3% | -$10.4K | 0.12% | 212 |
|
|
2020
Q3 | $261K | Sell |
569
-78
| -12% | -$35.8K | 0.14% | 252 |
|
|
2020
Q2 | $398K | Buy |
647
+44
| +7% | +$27.1K | 0.19% | 198 |
|
|
2020
Q1 | $287K | Sell |
603
-88
| -13% | -$41.9K | 0.12% | 228 |
|
|
2019
Q4 | $401K | Buy |
691
+329
| +91% | +$191K | 0.07% | 253 |
|
|
2019
Q3 | $238K | Sell |
362
-21
| -5% | -$13.8K | 0.05% | 221 |
|
|
2019
Q2 | $296K | Buy |
+383
| New | +$296K | 0.06% | 224 |
|
|
2019
Q1 | – | Sell |
-594
| Closed | -$278K | – | 269 |
|
|
2018
Q4 | $278K | Sell |
594
-190
| -24% | -$88.9K | 0.05% | 137 |
|
|
2018
Q3 | $676K | Sell |
784
-561
| -42% | -$484K | 0.07% | 78 |
|
|
2018
Q2 | $927K | Sell |
1,345
-304
| -18% | -$210K | 0.82% | 12 |
|
|
2018
Q1 | $735K | Buy |
1,649
+881
| +115% | +$393K | 0.64% | 90 |
|
|
2017
Q4 | $338K | Buy |
768
+243
| +46% | +$107K | 0.42% | 106 |
|
|
2017
Q3 | $259K | Buy |
525
+48
| +10% | +$23.7K | 0.03% | 138 |
|
|
2017
Q2 | $264K | Sell |
477
-423
| -47% | -$234K | 0.04% | 139 |
|
|
2017
Q1 | $596K | Buy |
900
+86
| +11% | +$57K | 0.11% | 98 |
|
|
2016
Q4 | $272K | Buy |
+814
| New | +$272K | 0.08% | 119 |
|
|
2016
Q2 | – | Sell |
-452
| Closed | -$101K | – | 149 |
|
|
2016
Q1 | $101K | Sell |
452
-29
| -6% | -$6.48K | 0.14% | 144 |
|
|
2015
Q4 | $292K | Buy |
+481
| New | +$292K | 0.8% | 34 |
|